Teraputix
Teraputix provides an innovative technology called Temperature Moderated & Collision Mediated Coating (TM & CMC) which delivers cost and clinical benefits to medical device companies seeking competitive advantage in the lucrative medical device coatings and drug delivery market. Key applications of the technology include orthopaedics, dental implants and cardiovascular stents and pacemakers which combined making up global markets totalling more than $50 billion in annual revenues.
TM & CMC has many advantages over existing coating methods including:
Biocompatibility:
- Deleterious chemicals are not included in the precursor composition;
- Therapeutics can be evenly distributed throughout the coating as polymer and therapeutics are concomitantly coated on the device; and
- Requirement for subsequent processing of the device is minimised reducing the opportunity for therapeutic degradation.
Manufacturability:
- Single-step process reduces processing time, labour costs etc.;
- Low flow rate of precursor composition ensures minimal waste of expensive therapeutic agents; and
- Combination of two existing equipment platforms, shot peeners and atomisers that are readily automated in a manufacturing setting.
Terapeutix